Avoid repeated freeze-thaw cycles and vigorous shaking, both of which can degrade peptide structure and affect the reliability of downstream satellite cell activation assays
Working 80 to 100-hour weeks to get the company underway did eventually take its toll on Oshmyansky
Can they help restore balance to a system that often feels unpredictable whether due to PCOS, menopause, or insulin resistance

Other links Review article advising resistance training in people taking GLP-1 agonists Paper that examines weight loss after 1 year of exercise or GLP-1 drugs More in-depth look at appetite and exercise behaviours in that study Study finding risk for RED-s in 30% of triathletes, including the tools that can be used to identify risk factors Cycling teams paying young riders big salaries More episodes View all episodes Why Anti-Doping Needs Target Testing and Investigation / Pogaar's Record Tour de France / The Weight-Loss Double Standard 01:10:38|Become a Supporter of The Real Science of Sport, and for the price of a coffee, or a gel, you get a bonus Applied episode every week, ad-free shows, and the best cycling and running community going over on Discourse.Show notesThis week we recap Tadej Pogaar's record-breaking Tour de France, and then get into the meat of it: why anti-doping leans so heavily on investigation and targeted testing, with insights from our interview with Brett Clothier, head of athletics' Athletics Integrity Unit.(02:24) Tadej Pogaar wins a fifth Tour de France in what Ross reckons is the most dominant display he has seen in any sport, and we dig into the numbers behind it, including an estimated 7 W/kg on Alpe d'Huez that obliterates Pantani's old mark, why the yellow jersey was effectively settled by stage six, and why the racing everywhere else still made it a decent watch.(13:55) The weight-loss double standard

A practitioner for over 25 years, Koff is leading a transformative movement in personalized nutrition, turning better, not perfect choices into practical, sustainable strategies that deliver real health outcomes
H.et al (2023)